Akazawa M - Search Results

1

Cost and utilization of COPD and asthma among insured adults in the US.

Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Blanchette CM, et al. Among authors: akazawa m. Curr Med Res Opin. 2009 Jun;25(6):1385-92. doi: 10.1185/03007990902875927. Curr Med Res Opin. 2009. PMID: 19419342

2

Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.

Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM. Rascati KL, et al. Among authors: akazawa m. Clin Ther. 2007 Jun;29(6):1203-13. doi: 10.1016/j.clinthera.2007.06.006. Clin Ther. 2007. PMID: 17692734

3

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Blanchette CM, et al. Among authors: akazawa m. J Manag Care Pharm. 2008 Mar;14(2):176-85. doi: 10.18553/jmcp.2008.14.2.176. J Manag Care Pharm. 2008. PMID: 18331119 Free PMC article.

4

Burden of concomitant asthma and COPD in a Medicaid population.

Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Shaya FT, et al. Among authors: akazawa mo. Chest. 2008 Jul;134(1):14-9. doi: 10.1378/chest.07-2317. Epub 2008 Mar 13. Chest. 2008. PMID: 18339789

5

Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.

Akazawa M, Hayflinger DC, Stanford RH, Blanchette CM. Akazawa M, et al. Am J Manag Care. 2008 Jul;14(7):438-48. Am J Manag Care. 2008. PMID: 18611095 Free article.

6

Economic burden prior to COPD diagnosis: a matched case-control study in the United States.

Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Akazawa M, et al. Respir Med. 2008 Dec;102(12):1744-52. doi: 10.1016/j.rmed.2008.07.009. Epub 2008 Aug 28. Respir Med. 2008. PMID: 18760581 Free article.

7

Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.

Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Blanchette CM, et al. Among authors: akazawa m. Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005. Am J Geriatr Pharmacother. 2008. PMID: 18775388

8

Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims.

Akazawa M, Stearns SC, Biddle AK. Akazawa M, et al. Health Serv Res. 2008 Dec;43(6):2164-82. doi: 10.1111/j.1475-6773.2008.00879.x. Epub 2008 Jul 29. Health Serv Res. 2008. PMID: 18671750 Free PMC article.

9

Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.

Akazawa M, Biddle AK, Stearns SC. Akazawa M, et al. Clin Ther. 2008;30 Spec No:1003-16. doi: 10.1016/j.clinthera.2008.05.020. Clin Ther. 2008. PMID: 18640475

10

Single-inhaler combination therapy for asthma: a review of cost effectiveness.

Akazawa M, Stempel DA. Akazawa M, et al. Pharmacoeconomics. 2006;24(10):971-88. doi: 10.2165/00019053-200624100-00005. Pharmacoeconomics. 2006. PMID: 17002480 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters